Eli lilly puts 100m plus billions backend form 5 target deal innocare

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 12:07 UTC

Eli Lilly has committed $100 million in upfront and near-term payments to InnoCare Pharma to form a five-target drug discovery pact. The deal features up to $3.25 billion in milestones.

fintechscience

Sources

• T2Eli lilly puts 100m plus billions backend form 5 target deal innocareFierce Biotech / Fierce Healthcare / MedCity / GEN24 Sept, 12:07